Page 7 - வசந்த சந்தித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GeneLeap Announces Novel GalNAc Synthesis and Evaluation in Mice as Antisense Oligonucleotide Conjugates at ACS 2021 News provided by Share this article Share this article BOSTON, April 25, 2021 /PRNewswire/ GeneLeap Biotech, a subsidiary of Luye Life Sciences specializing in the development of nucleic acid therapeutics, presented an e-poster entitled Design and synthesis of novel GalNAc linker moieties, conjugation to antisense oligonucleotides and evaluation in mice at the Spring Meeting of the American Chemical Society (ACS) 2021. The study reported new synthetic methodologies for the synthesis of novel tri-antennary GalNAc units and their evaluation for delivery and efficacy as GalNAc-antisense oligo conjugates in mice.

United statesJason zhangSean fuLuye life sciencesSpring meeting of the american chemical societyLeap biotechSpring meetingAmerican chemical societyGeneleap biotechஒன்றுபட்டது மாநிலங்களில்ஜேசன் ஜாங்சீன் ஃபூலூயே வாழ்க்கை அறிவியல்வசந்த சந்தித்தல்அமெரிக்கன் இரசாயன சமூகம்